These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37716833)

  • 1. Comparison of cardiovascular risk in co-existent primary aldosteronism and obstructive sleep apnea with neither or either alone in hypertension.
    Heizhati M; Li N; Zhu Q; Hong J
    Eur J Intern Med; 2023 Dec; 118():146-148. PubMed ID: 37716833
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation of a formal sleep center-based screening protocol for primary aldosteronism in patients with obstructive sleep apnea.
    Wright K; Mahmoudi M; Agrawal N; Simpson H; Lui MS; Pachter HL; Patel K; Prescott J; Suh I
    Surgery; 2023 Jan; 173(1):59-64. PubMed ID: 36198493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Aldosteronism and Obstructive Sleep Apnea: Casual Association or Pathophysiological Link?
    Pecori A; Buffolo F; Pieroni J; Forestiero V; Sconfienza E; Veglio F; Mulatero P; Monticone S
    Horm Metab Res; 2020 Jun; 52(6):366-372. PubMed ID: 32219799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Primary Aldosteronism is Underutilized in Patients with Obstructive Sleep Apnea.
    Conroy PC; Hernandez S; Graves CE; Menut KC; Pearlstein S; Liu C; Shen WT; Gosnell J; Sosa JA; Roman S; Duh QY; Suh I
    Am J Med; 2022 Jan; 135(1):60-66. PubMed ID: 34508708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
    Loh HH; Sukor N
    Front Endocrinol (Lausanne); 2022; 13():976979. PubMed ID: 36246876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Consequences of Obstructive Sleep Apnea.
    Dredla BK; Castillo PR
    Curr Cardiol Rep; 2019 Nov; 21(11):137. PubMed ID: 31707504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of primary aldosteronism in patients with concomitant hypertension and obstructive sleep apnea, baseline data of a cohort.
    Heizhati M; Aierken X; Gan L; Lin M; Luo Q; Wang M; Hu J; Maimaiti N; Duiyimuhan G; Yang W; Yao L; Zhu Q; Li N
    Hypertens Res; 2023 Jun; 46(6):1385-1394. PubMed ID: 36882631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary aldosteronism and obstructive sleep apnea: the strong ties between them.
    Sugawara A; Shimada H; Otsubo Y; Kouketsu T; Yokoyama A
    Hypertens Res; 2023 Jul; 46(7):1712-1713. PubMed ID: 37160968
    [No Abstract]   [Full Text] [Related]  

  • 9. Sleep apnea: why a good night's sleep is good for your health.
    McHenry Martin C
    Consult Pharm; 2007 May; 22(5):380-2, 385-8, 391-2. PubMed ID: 17658956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.
    Pedrosa RP; Drager LF; Gonzaga CC; Sousa MG; de Paula LK; Amaro AC; Amodeo C; Bortolotto LA; Krieger EM; Bradley TD; Lorenzi-Filho G
    Hypertension; 2011 Nov; 58(5):811-7. PubMed ID: 21968750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for primary aldosteronism in the hypertensive obstructive sleep apnea population is cost-saving.
    Chomsky-Higgins Menut K; Pearlstein SS; Conroy PC; Roman SA; Shen WT; Gosnell J; Sosa JA; Duh QY; Suh I
    Surgery; 2022 Jan; 171(1):96-103. PubMed ID: 34238603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Screening for Primary Aldosteronism in Patients With Suspected Obstructive Sleep Apnea.
    Chee MR; Hoo J; Libianto R; Gwini SM; Hamilton G; Narayan O; Young MJ; Fuller PJ; Yang J
    Hypertension; 2021 Jun; 77(6):2094-2103. PubMed ID: 33896193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Yeghiazarians Y; Jneid H; Tietjens JR; Redline S; Brown DL; El-Sherif N; Mehra R; Bozkurt B; Ndumele CE; Somers VK
    Circulation; 2021 Jul; 144(3):e56-e67. PubMed ID: 34148375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension].
    Waeber B; Feihl F
    Rev Med Suisse; 2012 Jan; 8(323):28-30. PubMed ID: 22303736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Aldosteronism and Obstructive Sleep Apnea: Is This A Bidirectional Relationship?
    Prejbisz A; Kołodziejczyk-Kruk S; Lenders JWM; Januszewicz A
    Horm Metab Res; 2017 Dec; 49(12):969-976. PubMed ID: 29202496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities.
    Turcu AF; Nhan W; Grigoryan S; Zhang L; Urban C; Liu H; Holevinski L; Zhao L
    J Am Heart Assoc; 2022 Jul; 11(14):e025952. PubMed ID: 35861830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstructive sleep apnea and cardiovascular disease.
    Calvin AD; Somers VK
    Curr Opin Cardiol; 2009 Nov; 24(6):516-20. PubMed ID: 19644364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].
    Zuo FJ; Zhou XH; Ren Y; Chen T; Tian HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):298-303. PubMed ID: 32543133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiology May Be the Key: Cardiovascular Risk Stratification in Obstructive Sleep Apnea.
    Singh B
    Am J Respir Crit Care Med; 2021 Jun; 203(12):1458-1460. PubMed ID: 33651665
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular Risks and Organ Damage in Secondary Hypertension.
    Cingolani OH
    Endocrinol Metab Clin North Am; 2019 Dec; 48(4):657-666. PubMed ID: 31655768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.